Drug resistance - Strategic Insights Report (Page 2)

Drug resistance

Tuberculosis Treatment Outcomes in South Africa: Analysis of Multidrug-Resistant Cases

Researchers from the University of KwaZulu-Natal have conducted a retrospective study to assess treatment outcomes of patients receiving the nine-month short regimen for rifampicin-resistant and multidrug-resistant tuberculosis (RR/MDR-TB) in uMkhanyakude District, South Africa. The study, published in BMC Infectious Diseases, aimed to identify socio-demographic and clinical factors associated with

Drug resistance

HIV Drug Resistance Remains a Significant Challenge in Sub-Saharan Africa

Investigations in sub-Saharan Africa (SSA) have highlighted the persistence of HIV drug resistance (HIVDR) as a critical challenge in the region. Despite efforts to combat the issue, HIVDR remains a significant hurdle in SSA due to limited effective treatment and healthcare resources. Researchers have conducted a study using the first

Cancer genetics

New Insights into Multiple Myeloma: NR5A2's Role in Disease Progression and Drug Resistance

Scientists at Fudan University have made significant discoveries in understanding the mechanisms of multiple myeloma, a type of blood cancer. According to a recent study, NR5A2, a transcriptional regulator of lipid metabolism, plays a crucial role in disease progression and drug resistance. The research, published in the International Journal of

Digoxin

Digoxin and Sodium Valproate Show Potential in Drug-Resistant Epilepsy Treatment

Current research by National University of Pharmacy suggests that cardiac glycoside digoxin may be an effective adjuvant to classical antiepileptic drugs (AEDs) in treating drug-resistant epilepsy. The study aims to elucidate the role of individual markers of neuroinflammation and neuronal apoptosis in the realization of the anticonvulsant potential of digoxin

Drug resistance

New Research Offers Hope for Treatment-Resistant Focal Epilepsy

A new study, part of the international Human Epilepsy Project, has found that even people with focal epilepsy who are deemed treatment-resistant may experience a significant reduction in seizures over time. The research, which tracked over 150 adults who had tried at least four different anti-seizure medications, found that 68%

Drug resistance

Breakthrough in Pancreatic Cancer Research: Identifying Key Genes for Effective Treatment

Current study results have unveiled significant insights into pancreatic ductal adenocarcinoma (PDAC), a highly lethal cancer characterized by drug resistance. Research conducted at Peking Union Medical College Hospital in Beijing, China, has pinpointed two key genes, EDC4 and USP20, as crucial components in PDAC chemoresistance. The study employed cytotoxicity assays,

Drug resistance

Breakthroughs in Pancreatic Cancer Treatment: Overcoming Drug Resistance with Precision Nano-Interventions

Scientists at Henan University have made significant progress in developing novel treatments for pancreatic cancer, one of the most aggressive forms of the disease. According to a recent study published in Nanoscale Advances, researchers have discovered ways to overcome the complex tumor microenvironment that makes pancreatic cancer so challenging to

Tuberculosis

Mycobacterium Tuberculosis Lineage 1: A Neglected Cause of Tuberculosis

Research at the Swiss Tropical and Public Health Institute has shed light on the significant contribution of Mycobacterium tuberculosis complex (MTBC) lineage 1 (L1) to human tuberculosis (TB) cases, particularly in low- to middle-income countries in South and Southeast Asia, and East Africa. Despite its restricted geographical range, L1 is

Tuberculosis

New Tuberculosis Data Reported by Researchers at University of Liverpool School Tropical Medicine

Researchers at the University of Liverpool School Tropical Medicine have presented data on a new treatment regimen for drug-resistant tuberculosis (TB). The study, which took place from January 2020 to December 2023, compared a standard injectable-containing regimen to an all-oral regimen for multidrug- and rifampicin-resistant TB (MDR/RR-TB). The results

Tuberculosis

Multidrug-Resistant Tuberculosis Complicated by Pulmonary Aneurysms Requires Prompt Intervention

Multidrug-resistant tuberculosis (MDR-TB) continues to pose a significant clinical challenge, particularly when accompanied by life-threatening complications such as hemoptysis. A recent study reports a rare but serious cause of hemoptysis in TB patients, which is the development of pulmonary artery pseudoaneurysms, known as Rasmussen aneurysms. These aneurysms typically arise within

Tuberculosis

Novel Compound from Datura innoxia Shows Promising Results Against Mycobacterium tuberculosis

Researchers from PMAS-Arid Agriculture University Rawalpindi have identified a potent phytocompound, o-vanillin, from the plant Datura innoxia that exhibits significant antitubercular activity against the Mycobacterium tuberculosis H37Ra strain. The study, published in Scientific Reports, highlights the compound's potential as a drug against tuberculosis (TB). The researchers employed in

Drug resistance

Nanocomposites Show Promise in Eradicating Mosquito-Larvae

Researchers at the Karpagam Academy of Higher Education have discovered that nanocomposites can be effective in suppressing the growth and development of mosquito larvae, which are the primary vectors for diseases such as malaria, filariasis, and dengue. The study, published in the Beni-Suef University Journal of Basic and Applied Sciences,

See all